On April 15, 2025, President Trump issued an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order reaffirms and seeks to expand on policy initiatives introduced during the president’s...more
4/21/2025
/ Biosimilars ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Imports ,
Inflation Reduction Act (IRA) ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs
When startups seek funding, the conversation often centers on market size, traction, or revenue models. Yet intellectual property (IP) is just as pivotal. A robust IP strategy not only boosts valuation but also reassures...more
2/19/2025
/ Asset Valuations ,
Capital Raising ,
Entrepreneurs ,
Innovation ,
Intellectual Property Protection ,
Investors ,
IP Portfolio ,
Patents ,
Startups ,
Trade Secrets ,
Trademarks ,
Valuation ,
Venture Capital
As an investor, you know that a startup’s intellectual property (IP) can be among its most valuable assets. A strong IP portfolio not only helps secure a company’s unique market position but also reduces competitive threats...more
On November 20, the United States Patent and Trademark Office (USPTO) issued a final rule adjusting patent fees beginning in 2025. According to the Office, the new fee schedule will increase fee collections by approximately...more
On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price...more